Page last updated: 2024-10-29

whi p154 and Breast Cancer

whi p154 has been researched along with Breast Cancer in 2 studies

WHI P154: an anti-leukemic agent; structure in first source

Research Excerpts

ExcerptRelevanceReference
"In MCF-7 breast carcinoma cells Orai1 and NCX1 have previously been shown to be modified by pharmacological inhibition of Janus activated kinase JAK2."1.43Down-Regulation of Store-Operated Ca2+ Entry and Na+ Ca2+ Exchange in MCF-7 Breast Cancer Cells by Pharmacological JAK3 Inhibition. ( Hosseinzadeh, Z; Lang, F; Yan, J; Zhang, B, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yan, J1
Zhang, B1
Hosseinzadeh, Z1
Lang, F1
Sudbeck, EA1
Ghosh, S1
Liu, XP1
Zheng, Y1
Myers, DE1
Uckun, FM1

Reviews

1 review available for whi p154 and Breast Cancer

ArticleYear
Tyrosine kinase inhibitors against EGF receptor-positive malignancies.
    Methods in molecular biology (Clifton, N.J.), 2001, Volume: 166

    Topics: Adenocarcinoma; Amides; Aniline Compounds; Animals; Antineoplastic Agents; Breast Neoplasms; Drug De

2001

Other Studies

1 other study available for whi p154 and Breast Cancer

ArticleYear
Down-Regulation of Store-Operated Ca2+ Entry and Na+ Ca2+ Exchange in MCF-7 Breast Cancer Cells by Pharmacological JAK3 Inhibition.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 38, Issue:4

    Topics: Adenosine Triphosphate; Breast Neoplasms; Calcium; Down-Regulation; Female; Fura-2; Humans; Janus Ki

2016